Longevity Services & Practice Library

Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.

All Library Articles Presentations Spotlights News

Showing 97–120 of 145

Peter Attia MDMar 2, 2026

#382 ‒ AMA #80: Longevity optimization through strength benchmarks, VO₂ max targets, nutrition principles, brain health, supplements, GLP-1 RAs, wearables, and more

Exercise emerges as the most protective intervention for brain health across the lifespan, with specific performance benchmarks in strength and aerobic capacity serving as measurable proxies for cognitive preservation and longevity. This positions physical capacity as a foundational biomarker that integrates multiple physiological systems rather than a secondary health outcome.

Longevity.TechnologyFeb 24, 2026

Antiaging shifts upstream as cell wellness gains traction

The personal care and longevity industry is shifting from treating visible signs of aging to supporting cellular health upstream, positioning products as maintenance tools for biological function rather than cosmetic fixes. This repositioning extends the customer lifecycle while aligning consumer expectations with the biological mechanisms of aging.

LifeSpan.ioApr 1, 2026

Rejuvenation Roundup March 2026

This roundup summarizes March 2026 longevity research across multiple domains: mechanisms linking energy production to neurodegeneration, exercise's effect on brain aging, immunosenescence factors, organ-level aging processes, and the interconnection between microbiome composition, psychological state, and systemic aging. The findings collectively advance understanding of how interventions—from resistance training to nutritional composition to social environment—modulate the rate of age-related decline.

Peter Attia MDMar 23, 2026

#385 – AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more

This AMA addresses practical applications of longevity science across disease prevention, body composition assessment, nutritional strategy, movement quality, and habit implementation. The focus is on translating evidence-based tools into sustained clinical and personal practice for extending both lifespan and healthspan.

Longevity.TechnologyMar 11, 2026

Capriroso launches platform for athlete longevity

Capriroso's platform interprets biometric data across weeks and months rather than daily snapshots, helping endurance athletes recognize long-term physiological patterns and make training decisions based on cumulative stress and recovery trends. This approach addresses a gap where abundant data has not improved understanding, potentially extending athletic lifespan through sustainable training practices.

Longevity.TechnologyApr 16, 2026

Your immune system now has a digital twin for longevity

A digital twin technology modeling immune system dynamics in real time enables predictive health outcomes rather than reactive assessment. This shift from static testing to continuous simulation represents a substantive advance in personalized longevity medicine.

LT WireApr 22, 2026

Insilico forms longevity board to oversee AI aging research

Insilico Medicine established an oversight board combining pharmaceutical expertise with longevity science to accelerate AI-driven drug discovery targeting aging hallmarks. The initiative aims to translate experimental compounds into validated therapeutics across fibrosis, oncology, immunology, and metabolic disease.

LT WireMar 11, 2026

Allosteric Bioscience targets longevity research using AI and quantum computing

Allosteric Bioscience is using AI and quantum computing to model molecular mechanisms of aging, targeting pathways including Lamin A, tryptophan metabolism, DNA repair, and mitochondrial function. The approach aims to identify modulators that could reduce age-related disease and extend lifespan.

Longevity.TechnologyApr 24, 2026

Insilico forms industry’s first AI Longevity Board

Insilico Medicine has established an industry-focused Longevity Board to guide AI-driven drug development targeting aging itself rather than individual diseases. The board represents a shift from academic longevity research toward pharmaceutical scalability, with leadership from both the biotech sector and major pharmaceutical companies.

LT WireMay 11, 2026

Abu Dhabi’s “Future Health” initiative targets longevity, predictive care

Abu Dhabi is establishing a large-scale health infrastructure combining genomic, phenotypic, and wearable data with AI to enable predictive care and accelerate drug discovery. This represents a shift toward population-level early detection and prevention rather than reactive treatment models.

Longevity.TechnologyMar 12, 2026

AI app puts longevity data in your pocket

Human Longevity has launched a mobile application that consolidates clinical data, biomarkers, genetic information, and imaging results into a continuous health record accessible to users. The platform uses AI to identify patterns across longitudinal data, shifting preventive health assessment from episodic annual checkups to real-time risk monitoring and interpretation.

Longevity.TechnologyApr 13, 2026

Function acquires Getlabs to scale at-home testing

Function's acquisition of Getlabs removes logistical friction from routine health testing by bringing blood draws directly to patients' homes and offices. This operational change addresses a fundamental barrier to consistent health monitoring—the primary prerequisite for sustained, data-driven health optimization.

LT WireMay 8, 2026

Executive Health program condenses three months of testing into six hours

Biograph's Executive Physical consolidates comprehensive cardiovascular, metabolic, cancer, and neurological screening into a single six-hour appointment using whole-body MRI, advanced CT, and biomarker analysis. This integrated approach identifies significant health findings in approximately 17 percent of participants and demonstrates measurable metabolic improvements in follow-up assessments.

Longevity.TechnologyMar 30, 2026

Global rallies call for aging to be treated

Coordinated global demonstrations are pressuring governments to fund geroscience research and establish regulatory pathways that recognize aging as a treatable medical condition. The rallies highlight a critical gap between accelerating scientific advances in longevity research and stalled policy frameworks that remain anchored to disease-specific treatment models.

Longevity.TechnologyFeb 20, 2026

L-Nutra named Innovator Partner for the Longevity Show 2026

L-Nutra's fasting-mimicking technology platform, validated across 47 clinical trials and 18 university research centers, repositions precision nutrition as essential healthcare infrastructure rather than lifestyle optimization. The company's approach uses targeted nutrient formulations to trigger cellular repair mechanisms—autophagy and metabolic signaling—without the physiological stress of extended fasting, addressing metabolic dysfunction and age-related chronic disease at a systems level.

LifeSpan.ioApr 8, 2026

Life Bio’s Trial: Is the FDA Warming to Rejuvenation?

Life Biosciences' ER-100, a cellular reprogramming therapy, has received FDA clearance for human trials targeting optic nerve disorders. The trial represents a regulatory shift toward rejuvenation-based approaches, potentially positioning cellular age-reversal technologies within mainstream clinical frameworks rather than relegating aging to inevitability.

Nature - npj AgingFeb 16, 2026

Biological age and immunosenescence in Colombian centenarians

Colombian centenarians show delayed immunosenescence and younger biological age despite chronological longevity, suggesting that immune system resilience rather than mere longevity is the critical predictor of healthspan. This finding reframes centenarian research toward understanding which mechanisms preserve immune function across decades.

Longevity.TechnologyMar 27, 2026

SEMCAP expands into beauty’s longevity opportunity

SEMCAP's expansion into beauty and wellness investment signals a structural shift in longevity markets: evidence-backed skincare, haircare, and personalized health products are becoming primary entry points for consumer engagement with aging well, driven by daily rituals and observable body signals rather than clinical diagnostics alone.

Longevity.TechnologyMar 5, 2026

Lancôme ties up with Timeline to target skin’s biological age

Lancôme and Timeline have partnered to develop a skincare line using urolithin A (Mitopure), a molecule that enhances mitochondrial function in skin cells to address aging at the cellular level rather than merely treating visible signs. This represents a shift in luxury skincare from cosmetic coverage to supporting long-term cellular vitality and resilience.

Longevity.TechnologyFeb 23, 2026

AI’s role in the next era of longevity biotech

Artificial intelligence is compressing drug discovery timelines from four to five years to approximately fourteen months by automating target identification, molecular design, and clinical trial prediction. This acceleration has direct implications for longevity therapeutics, where speed to market can determine whether interventions reach patients before age-related decline progresses beyond intervention points.

Longevity.TechnologyApr 21, 2026

Energy Span reframes fatigue as early warning

Energy Span reframes fatigue as a quantifiable, systems-level signal of healthspan decline that emerges before conventional biomarkers shift into pathological ranges. This perspective bridges the gap between subjective experience and measurable biology, positioning energy as an early warning system reflecting mitochondrial function, metabolic flexibility, circadian rhythm, and autonomic regulation operating in concert.

Longevity.TechnologyMar 4, 2026

WHOOP enters $34.5m ARPA-H-backed bid to quantify aging

WHOOP has joined a $34.5 million Stanford-led research initiative to develop the first FDA-grade Intrinsic Capacity score, a predictive model designed to quantify functional healthspan and forecast major health outcomes up to 20 years in advance. The THRIVE coalition integrates continuous wearable physiological data with clinical biomarkers and functional assessments to measure resilience and detect early shifts toward vulnerability before disease manifests.

Longevity.TechnologyFeb 19, 2026

AI-driven food app targets disease prevention and aging

Foodhak uses AI-driven personalization to translate nutrition science into daily food guidance aligned with individual health markers and goals. The approach positions food as preventive medicine rather than caloric constraint, addressing a systemic gap where most food choices optimize for taste and cost rather than long-term health outcomes.

Longevity.TechnologyMar 24, 2026

Biophytis-LynxKite AI alliance broadens longevity drug pipeline

Biophytis and LynxKite are expanding their AI-driven drug discovery partnership beyond sarcopenia to build a broader platform for age-related diseases, including dry age-related macular degeneration. The alliance demonstrates a concrete application of AI to accelerate candidate identification and reduce development timelines in longevity therapeutics.

Biological EDGE

Biohacking Starts With NO